Parse Nixes 10x Genomics Cell-Analysis Patent at Tribunal (1)

Parse Biosciences Inc. persuaded an administrative tribunal to invalidate a 10x Genomics Inc. cell-analysis patent its products are accused of infringing.

The methods for analyzing nucleic acids from single cells covered by 10x’s US Patent No. 10,155,981 are obvious in light of two prior printed publications, according to a decision issued Tuesday by the Patent Trial and Appeal Board.

10x disagrees with the decision and plans to appeal, Vice President Kristen Cardillo told Bloomberg Law in an email.

10x filed a lawsuit against Parse in August 2022, alleging Parse’s Evercode WT products and its single-cell test infringe three of its ...